Vlaming, Hanneke https://orcid.org/0000-0003-1743-6428
Mimoso, Claudia A.
Field, Andrew R. https://orcid.org/0000-0002-9016-7917
Martin, Benjamin J. E. https://orcid.org/0000-0002-2296-6346
Adelman, Karen https://orcid.org/0000-0001-5364-334X
Article History
Received: 4 July 2021
Accepted: 28 April 2022
First Online: 9 June 2022
Competing interests
: K. A. is a consultant for Syros Pharmaceuticals, is on the scientific advisory board of CAMP4 Therapeutics, and receives research funding from Novartis unrelated to this work. The remaining authors declare no competing interests.